Remote Pathology Growth Aperio's network-enabled ePathology platform enables remote, simultaneous, real-time viewing and easy distribution for consults across hospitals, reference labs, pharma and research institutions; ideal for multi-site pathology programs, second opinions, and telepathology initiatives; supports opportunities in centralized pathology services and CRO collaborations.

Analytics Driven Value PRECISION analytics tools provide advanced pathology capabilities that can be upsold to labs and pharma for AI-assisted diagnosis, biomarker analysis and research workflows; target customers expanding personalized medicine programs; potential ROI from faster turnaround times and improved diagnostic consistency.

System Integration Benefit Interoperable, scalable, secure web-based platform designed to integrate with LIS, PACS, EMR and other IT systems, enabling seamless workflow modernization; approach CIOs and IT leads in large health systems and academic centers seeking interoperable pathology data sharing.

Vendor Stability Advantage The company's history of acquisitions by BlackRock and prior connections to Leica Biosystems signal strong financial backing and long-term product support; leverage this to reassure procurement teams in large institutions evaluating durable digital pathology solutions.

Global Adoption Trend With a global footprint across hospitals, reference labs, pharma and research institutions and recent industry recognition, there is momentum for broader adoption; pursue international expansion and channel partnerships to scale digital pathology platforms.